Your insurer may be able to partially reimburse you for treatment via Mindbloom. After your first virtual visit, Mindbloom can provide you with a Superbill to submit to your insurance provider.
Lack of or incomplete coverage for ketamine therapy could be due to any number of factors including because it is prescribed “off-label.” Ketamine was approved by the FDA in 1970 as an anesthetic and has been used to treat mental health conditions for more than 20 years. Because generic ketamine has not been approved by the FDA specifically for the treatment of depression and anxiety, most insurers choose not to cover it. Fortunately, research is currently advancing multiple psychedelic medicines toward FDA approval. This includes generic ketamine’s application in treating a number of conditions.